However, besides its pro-fibrotic properties, TGF-β1 exerts a number of other homeostatic functions in immune and cancer biology [5], so that inhibition of TGF-β1 would provoke a series of adverse effects, making it not that valuable as a therapeutic approach. Here, TGFB1 is linked to cancer.